Project 1 - Moderna marcus

docx

School

University of Maryland, University College *

*We aren’t endorsed by this school

Course

110

Subject

Management

Date

Feb 20, 2024

Type

docx

Pages

Uploaded by misskitty1234

Running head: ALL CAPS FOR TITLE 1 Moderna Project Marcus Hamilton Jr BMGT 110 6383 Dr. Howell

ALL CAPS FOR TITLE 2 Introduction Moderna is a pharmaceutical organization that creates and produces medications and immunizations using messenger RNA (mRNA) devices. The city of Cambridge serves as the organization's corporate headquarters. It was established in 2010. The organization plan will build a fresh category of breakthrough pharmaceuticals to consumers as well as speed up the research, creation, and marketing of mRNA pharmaceuticals and antibodies. This produces mRNA prescription drugs for pain, heart problems, and viruses. This essay provides an outline of the organization while analyzing their goals, kind of operations, funding stakeholder foundation, rules, and level of rivalry. There is a need for knowledge on these issues among the organizations. Moderna’s business and purpose Moderna's main focus is the research and manufacture of mRNA therapeutics and vaccines. The company's mRNA technology platform makes it possible to cure diseases including cancer, infectious diseases, unusual genetic defects, and other conditions fast (Iansiti et al., 2020). One of the most promising products for Moderna is a COVID-19 vaccine that has been approved for use in emergencies by the CDC, WHO of the US (FDA), and many other governing bodies around the world. Several more cancer treatments, rare genetic disorders, and influenza and CMV vaccines are in various stages of development at the company. Identify Moderna’s stakeholders! Stakeholders include the company's shareholders, workers, clients, vendors, and local communities where it conducts business. The success of a firm is important to both its shareholders and its employees since it creates growth prospects for both groups (Iansiti et al., 2020). The company's goods and services are sought after by clients including drugs

ALL CAPS FOR TITLE 3 companies and administrations. The environments in which an organization works is impacted by the firm's existence and process, while traders supply an organization with the goods and services it requires to function. Explain how the social environment has shaped Moderna's business activities! Moderna's commercial operations have been greatly influenced by society as a whole. The general population's increasing focus on care is a major societal factor that has impacted the organization. Due to increased public awareness, there is a greater need for new medications and vaccinations to combat illnesses like COVID-19, unusual inheritable conditions, and disease (Sung et al., 2021). To fulfill this demand, Moderna focus is creating mRNA treatments and immunizations. The increasing importance of environmental protection and social responsibility for companies is another element in the community's conditions which impacts Moderna's operations. Because of this, the organization now prioritizes the good health and happiness of its workers, clients, and the areas that involves company conducts business (Sung et al., 2021). The business has achieved this through making investments in R&D, putting responsible corporate processes into place, while aiding the community through participation and giving back. Through rules and competition, business and government have had an effect on Moderna's goods. The development and popularity of Moderna's goods have been greatly influenced by both private and public sectors. While at the same time providing financing for advancement studies, government control in Moderna's COVID-19 shot has ensured both its security and

Your preview ends here

Eager to read complete document? Join bartleby learn and gain access to the full version

Access to all documents
Unlimited textbook solutions
24/7 expert homework help

ALL CAPS FOR TITLE 4 success. The organization's attempts to develop and better its goods have been aided by strong rivalry in the drug sector (Kersan kabi, 2022). The organization's accomplishment of quickly producing and spreading a COVID-19 shot is evidence of the influence of government as well as business on the drug business. Yet the business community must also adhere to moral and constitutional guidelines, as well as rules governing the cost and accessibility of the goods (Kersan Kabi, 2022). The industry's rivalry encourages businesses to continually come up with new ideas and ways to enhance their goods, which helps to control pricing. Moderna financed its founding and expansion! With the help of wealthy individuals and angel investors, Moderna was established in 2010. Initial Public Offerings (IPOs), collaborative efforts, and entrepreneurship funds were used to finance its establishment and growth (Reiff, 2022). Investing capitalists including NorthStar Partners and Google Ventures contributed more than $2 billion to the organization. Additionally, Moderna established strategic alliances with pharmaceutical firms like Pfizer and the drug company Merck which contributed significant funds and assets. The organization collected around 600 million dollars in extra funding in 2018 after going global with an IPO (Reiff, 2022). Moderna was able to come up with its breakthrough technology and release products on shelves thanks to these diverse types of finance. It was also essential in providing capital for the organization's studying and trials, which ultimately resulted in the creation of the COVID-19 shot. Discuss possible trade barriers that have potentially affected Moderna's business and the effects they could have!

ALL CAPS FOR TITLE 5 There is a possibility that trade obstacles such as taxes and limits on the movement of goods will prevent Moderna from offering goods in some areas. Such challenges may raise operating expenses or restrict an organization's capacity to enter industries. The company may find it more challenging to acquire the required goods and services due to trade obstacles. The organization's financial success and expansion ability may be harmed by these obstacles. Conclusion Investors should carefully examine an organization's mission, operations, participants, governmental environment, rivals, and its economic health before committing to any capital. Having a study gives a broad picture of the company's financial health, possibilities of accomplishment, and potential for expansion over a specific time frame. In other words, Moderna uses mRNA technique to develop medicines and vaccines. Its primary business is the development and production of mRNA treatments and shots, especially its sights on the COVID-19 shots. The organization is up against rival drug companies using the mRNA method as well as laws like the FDA regulations. Given Moderna's quick development within the ten years of its founding and its projected steady expansion, investing in it is therefore a prudent decision. References References (to be used as an example)

ALL CAPS FOR TITLE 6 Center for Drug Evaluation and Research. (n.d.). Drug development and drug interactions . U.S. Food and Drug Administration. https://www.fda.gov/drugs/drug-interactions-labeling/drug- development-and-drug-interactions-possible-models-decision-making K. kabi. (2022). The Moderna covid-19 (mRNA-1273) vaccine: What you need to know . World Health Organization. https://www.who.int/news-room/feature-stories/detail/the-moderna- covid-19-mrna-1273-vaccine-what-you-need-to-know Iansiti et al., 2020 . (2023, March 30). Moderna Covid-19 vaccine . Centers for Disease Control and Prevention. https://www.cdc.gov/vaccines/covid-19/info-by-product/moderna/index.html Reiff, N. (2022, November 14). Best Biotech etfs . Investopedia. https://www.investopedia.com/articles/investing/081415/top-3-biotech-etfs.asp Moderna Announces Advances Across mRNA Pipeline and Provides Business Update. (2020).https://news.modernatx.com/news/news-details/2023/Moderna-Announces- Advances-Across-mRNA-Pipeline-and-Provides-Business-Update/default.aspx Moderna announces first participant dosed in phase 3 pivotal registration study of its mrna cytomegalovirus (CMV) vaccine . Moderna Announces First Participant Dosed in Phase 3 Pivotal Registration Study of Its mRNA Cytomegalovirus (CMV) Vaccine. (n.d.). https://investors.modernatx.com/news/news-details/2021/Moderna-Announces-First-Participant- Dosed-in-Phase-3-Pivotal-Registration-Study-of-Its-mRNA-Cytomegalovirus-CMV-Vaccine/ default.aspx

Your preview ends here

Eager to read complete document? Join bartleby learn and gain access to the full version

Access to all documents
Unlimited textbook solutions
24/7 expert homework help

Related Documents

IPE Case Study Colin Crawford-1 (1) (2).docx

Org Analysis Midterm Paper - Sample 1.pdf

Mod 1 Conferences .docx

MLC - Mission Command & Operations study guide.pdf

Portfolio Project Topic, Stance and Counterargument.docx

7 eleven 2.docx

SU_NSG4029_W1_Project_Rodriguez_L.docx

TeamTeal_Session 11 .docx

Extra Credit Opportunity .docx

Unit 5 Assignment.docx

Unit 4 Draft.docx

Assessment 3_BSBPEF502.docx

Recommended textbooks for you

Management, Loose-Leaf Version

Management

ISBN:9781305969308

Author:Richard L. Daft

Publisher:South-Western College Pub

Purchasing and Supply Chain Management

Operations Management

ISBN:9781285869681

Author:Robert M. Monczka, Robert B. Handfield, Larry C. Giunipero, James L. Patterson

Publisher:Cengage Learning

MARKETING 2018

Marketing

ISBN:9780357033753

Author:Pride

Publisher:CENGAGE L

Marketing

ISBN:9780357033791

Author:Pride, William M

Publisher:South Western Educational Publishing

Principles of Management

Management

ISBN:9780998625768

Author:OpenStax

Publisher:OpenStax College

SEE MORE TEXTBOOKS

Recommended textbooks for you

Management, Loose-Leaf Version
Management
ISBN:9781305969308
Author:Richard L. Daft
Publisher:South-Western College Pub
Purchasing and Supply Chain Management
Operations Management
ISBN:9781285869681
Author:Robert M. Monczka, Robert B. Handfield, Larry C. Giunipero, James L. Patterson
Publisher:Cengage Learning
MARKETING 2018
Marketing
ISBN:9780357033753
Author:Pride
Publisher:CENGAGE L
Marketing
Marketing
ISBN:9780357033791
Author:Pride, William M
Publisher:South Western Educational Publishing
Principles of Management
Management
ISBN:9780998625768
Author:OpenStax
Publisher:OpenStax College